Summit Therapeutics (SMMT) SEC Filings & 10K Form

$4.39
+0.33 (+8.13%)
(As of 05/3/2024 ET)

Recent Summit Therapeutics SEC Filings

DateFilerForm TypeView
05/01/2024
7:45 AM
Summit Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/01/2024
7:18 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
7:11 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/15/2024
8:21 AM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
8:19 AM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/11/2024
3:35 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
4:52 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
4:43 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2024
4:47 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:42 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
7:27 PM
Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:28 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
7:07 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
7:36 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
11:15 PM
Summit Therapeutics (Filer)
Form EFFECT
02/20/2024
6:55 AM
Summit Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/20/2024
7:05 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
6:32 AM
Summit Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
4:25 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:35 PM
Summit Therapeutics (Issuer)
Xia Yu (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/08/2024
3:08 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
8:07 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:19 PM
Summit Therapeutics (Issuer)
Xia Yu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:22 PM
Mahatme Ujwala (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:24 PM
Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:16 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
4:11 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:49 PM
Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
7:08 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
7:03 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
3:06 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:08 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
6:46 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
2:40 PM
Summit Therapeutics (Filer)
Form DEF 14A
08/09/2023
7:03 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
3:05 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
7:43 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SMMT) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners